Eravacycline

Chemical formula: C₂₇H₃₁FN₄O₈  Molecular mass: 558.563 g/mol  PubChem compound: 54726192

Therapeutic indications

Eravacycline is indicated for:

Complicated intra-abdominal infections

Population group: only adults (18 years old or older)

Eravacycline is indicated for the treatment of complicated intra-abdominal infections (cIAI) in adults.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Eravacycline is contraindicated in the following cases:

Lactation

Lactation

Hypersensitivity to tetracycline class antibiotics

Tetracycline allergy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: XERAVA Powder for solution for infusion
Structured Product Labeling (SPL/PLR) 2020: XERAVA Powder for solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈